AD

Anjana Das

Active Director Director DIN 09322159
DIN 09322159 First appointment Sep 2021 Primary industry Professional Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Anjana Das

Data last updated:

Anjana Das is a Director at Unicore Biotech Private Limited (since 2021). The company operates in Professional Services. Unicore Biotech Private Limited reported revenue of ₹18.4 Lakh (FY 2025).

DIN 09322159
Primary Designation Director
Industry Professional Services
First Appointment 20 Sep 2021
Oldest Company Age 10 yrs
Largest company Unicore Biotech Private Limited · ₹18.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Unicore Biotech Private Limited U51909BR2016PTC031901
Director20 Sep 20212016₹18.4 Lakh (FY 2025)Active

Board colleagues of Anjana Das

Directorship timeline

Open interactive timeline →
Unicore Biotech Private Limited
Premium access

Shareholding and investment profile for Anjana Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjana Das

Anjana Das currently holds 1 directorship: Unicore Biotech Private Limited (Director, since 20 Sep 2021, revenue ₹18.4 Lakh (FY 2025)).

Anjana Das was first appointed on 20 Sep 2021 as Director at Unicore Biotech Private Limited.

The current boards of Anjana Das's companies include Huma Shams (Unicore Biotech Private Limited), Mithilesh Kumar (Unicore Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available